Filing Details
- Accession Number:
- 0001127602-13-021186
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-06-26 17:38:01
- Reporting Period:
- 2013-06-24
- Filing Date:
- 2013-06-26
- Accepted Time:
- 2013-06-26 17:38:01
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 920148 | Laboratory Corp Of America Holdings | LH | Services-Medical Laboratories (8071) | 133757370 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1275654 | P David King | 531 South Spring Street Burlington NC 27215 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-06-24 | 25,000 | $60.04 | 88,423 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-06-24 | 24,300 | $98.65 | 64,123 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-06-24 | 400 | $99.05 | 63,723 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-06-24 | 300 | $99.06 | 63,423 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-qualified Stock Options | Disposition | 2013-06-24 | 25,000 | $0.00 | 25,000 | $60.04 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 174,200 | 2010-02-11 | 2019-02-11 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 43,758 | Indirect | By grantor retained annuity trust |
Footnotes
- Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934.
- The price of $98.65 per share represents a weighted average of sales prices ranging from $98.04 to $99.03 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
- Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2008 Stock Incentive Plan.
- The option vested in three equal annual installments beginning on 2/11/2010 and is now fully exercisable.
Billionaire Hedge Funds
